What the Research Shows

Multiple large-scale studies and systematic reviews have compared telepsychiatry outcomes to in-person psychiatric care across a range of conditions including depression, anxiety disorders, PTSD, bipolar disorder, and schizophrenia. The consistent finding: for most patients, most of the time, outcomes are equivalent. In several specific contexts, telehealth patients actually do better.

The Data: A 2021 meta-analysis in the Journal of Psychiatric Research found no significant differences in therapeutic alliance, symptom improvement, patient satisfaction, or treatment adherence between telepsychiatry and in-person psychiatric care across 29 randomized controlled trials.

When Telehealth Is Actually Better

Research has identified several patient populations for whom telehealth outperforms in-person care:

  • Patients in rural areas — eliminating geographic barriers dramatically improves treatment initiation and retention
  • Patients with agoraphobia, social anxiety, or PTSD — attending from a safe home environment reduces avoidance and dropout
  • Patients with mobility limitations, chronic illness, or unreliable transportation — removing logistical barriers directly improves care continuity
  • Working parents and professionals — scheduling flexibility improves adherence to follow-up appointments
  • Patients in stigmatized communities — privacy of home-based care reduces avoidance of mental health treatment

When In-Person Remains Preferable

Telehealth is not appropriate for all situations. Certain assessments — such as detecting subtle neurological signs, performing urine drug screens, or administering Spravato® — require in-person visits. Patients in acute crisis or who require involuntary psychiatric evaluation must be seen in person or at an emergency facility. And some patients simply prefer the structure and presence of a physical office visit — which is a completely valid preference.

What This Means for UMG Patients

At UMG, we offer both modalities — and many patients use both, attending in-person for their initial evaluation or procedures like Spravato®, then managing ongoing medication follow-ups via telehealth. The best care is the care you actually access. Removing barriers to access is itself a clinical intervention.